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Abstract
DNA- and RNA-processing pathways are integrated and interconnected in the eukaryotic nucleus to allow efficient gene
expression and to maintain genomic stability. The recruitment of DNA Topoisomerase I (Topo I), an enzyme controlling DNA
supercoiling and acting as a specific kinase for the SR-protein family of splicing factors, to highly transcribed loci represents
a mechanism by which transcription and processing can be coordinated and genomic instability avoided. Here we show
that Drosophila Topo I associates with and phosphorylates the SR protein B52. Surprisingly, expression of a high-affinity
binding site for B52 in transgenic flies restricted localization, not only of B52, but also of Topo I to this single transcription
site, whereas B52 RNAi knockdown induced mis-localization of Topo I in the nucleolus. Impaired delivery of Topo I to a heat
shock gene caused retention of the mRNA at its site of transcription and delayed gene deactivation after heat shock. Our
data show that B52 delivers Topo I to RNA polymerase II-active chromatin loci and provide the first evidence that DNA
topology and mRNA release can be coordinated to control gene expression.
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Introduction
Messenger RNA (mRNA) transcribed by the RNA polymerase
II (RNA Pol II) undergoes several maturation steps: capping,
splicing and polyadenylation, before its export into the cytoplasm
(for review see [1]). All these steps are tightly coupled to ongoing
transcription so that RNA emerging from the polymerase is
immediately coated with RNA-binding proteins that participate in
RNA maturation, processing and assembly into an export-
competent mRNA-ribonucleoprotein (mRNP) [2,3]. Recent data
show that transcriptional and post-transcriptional events mutually
influence each other, revealing a reciprocal coupling. For example,
transcription speed can influence splicing of the transcript, and
factors involved in splicing of the emerging pre-mRNA can
modulate transcription [1,3]. Among the factors that have been
proposed to play a role in the coupling between transcription and
maturation of the pre-mRNAs is the DNA topoisomerase I (Topo
I), a protein that carries two enzymatic activities: a ‘topoisomerase’
activity that relaxes DNA supercoiling generated by transcription,
replication or chromatin dynamics and a ‘kinase’ activity that
phosphorylates RNA splicing factors [4,5].
Topo I is a type IB DNA topoisomerase that can relax both
negative and positive supercoils during transcription and replication
by introducing a single strand break into the DNA [6]. Although
Topo I is not essential in yeast [6,7], it is required for embryonic
development in Drosophila [8] and mice [9]. A large part of our
knowledge of Topo I activity has been obtained through the use of a
highlyspecificdrug,camptothecin,thattrapstheenzymeonceithas
cleaved the DNA [5]. This property allowed mapping of Topo I
cleavage sites which are scattered along regions of DNA that are
actively transcribed but it does not cleave the same regions when
theyaresilent.Animmediate effectofcamptothecinisthe inhibition
of transcription[5]that occurs dueto collisionof stalledTopo I with
transcribing RNA Pol II [10]. Through its action of relaxing the
positive supercoils generated ahead of, as well as negative supercoils
generated behind, transcribing RNA Pol II, it has been suggested
that Topo I plays a major role in transcription [11]. However there
is no direct evidence that the relaxing activity of Topo I drives the
elongation of transcription. Moreover, Topo I was shown to both
activate and repress transcription in reconstituted transcription
reactions [12,13]. These effects did not require the relaxation
activity of the protein and revealed a novel function of the enzyme
in the regulation of transcription initiation by RNA Pol II. Recent
data have shown that Topo I inhibition by camptothecin also
activated promoter-proximal transcription, indicating a role for the
enzyme in transcriptional pausing [14]. Therefore Topo I function
in transcription is not limited to a simple unwinding of DNA during
transcription elongation.
Topo I may participate in transcription through its action on
SR proteins. These proteins constitute a conserved family of
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alternative splicing, and are also involved in transport, translation
and decay of mRNAs [3,15]. More recently, SR proteins have also
been implicated in transcription elongation and genomic stability
[3]. Depletion of the SR protein SC35 diminishes the association
of RNA Pol II with the kinase P-TEFb which phosphorylates the
RNA Pol II C-Terminal Domain (CTD) and consequently
dramatically reduces the production of nascent RNA [3,16].
Through its capacity to phosphorylate SR proteins, Topo I has
been shown to modulate SR protein activity in splicing [17,18]
and to prevent replication fork collapse by suppressing the
formation of R-loops in an SR protein-dependent manner [19].
Therefore the presence of the topoisomerase and kinase activities
in the same protein may fulfill functions required to coordinate
transcription with RNA-processing events [4]. However, in vivo
evidence implicating Topo I in RNA metabolism is lacking and
this problem needs addressing with an integrated system.
In this study, we performed a genetic analysis in Drosophila to
demonstrate that Topo I modulates the SR protein B52
phosphorylation status in vivo. In addition to perfect co-localization
of both proteins on polytene chromosomes, we demonstrate that
B52 targets Topo I to transcription sites. Impaired recruitment of
Topo I following B52 depletion, induces an inefficient release of
hsp70 target mRNA from its transcription site and a delay in hsp70
shutdown. These genetic findings raise the intriguing possibility
that B52 and Topo I collaborate to release mRNPs and deactivate
transcription of target genes and help to explain genomic
instability and developmental defects associated with Topo I
depletion in metazoa.
Results
Drosophila Topo I harbors an intrinsic kinase activity that
modulates B52 phosphorylation in vivo
Mammalian Topo I protein has an intrinsic kinase activity that
phosphorylates the RS domain of SR proteins [20]. Kinase activity
of Topo I has not yet been reported for other species. We first
asked whether Drosophila Topo I can phosphorylate B52 protein in
vitro. Drosophila Topo I was expressed and purified from SF9 cells,
and incubated in the presence of radioactive ATP with purified
B52 expressed in bacteria. Topo I phosphorylates B52 in a dose-
dependant manner in vitro (Figure 1A), showing that the kinase
activity of the protein is conserved in Drosophila. We then asked
whether varying the level of Topo I in vivo could modify B52
phosphorylation status. To this end, proteins isolated from larvae
were resolved on two-dimensional (2D) gels and B52 phosphor-
ylation variants were analyzed by western blot. In wild type larvae,
B52 migrates as a large population of spots revealing numerous
post-translational modifications of the protein (Figure 1B). We first
analyzed B52 phosphorylation in the Topo I loss-of-function
mutant top1
77, which is lethal at the second instar larval stage [8].
In top1
77 larvae, B52 is displaced towards the basic part of the gel
(Figure 1B, panel top1
77) indicating that B52 is less phosphorylated
in this mutant. To test whether Topo I overexpression could
increase B52 phosphorylation in vivo, we developed transgenic flies
expressing the top1 coding sequence under the control of UAS
sequences (UAS-Topo I). Different insertions of the UAS-Topo I
transgene displayed variable response to GAL4 due to position
effects, as commonly observed. Figure 1C shows an example of
this variation seen in the wing disc with the en-Gal4 driver, which is
expressed in the posterior part of each segment. In the UAS-Topo
I#4 line, a weak overexpression of Topo I was detected, whereas a
strong overexpression was detected in the UAS-Topo I#11 line. We
expressed variable doses of Topo I under the control of the
ubiquitous da-Gal4 driver, using either the UAS-Topo I#4 or the
UAS-Topo I#11 insertions. da-Gal4/UAS-Topo I#4 individuals can
survive to adulthood, whereas da-Gal4/UAS-Topo I#11 individuals
die as first or second instar larvae. This observation correlates with
the strength of the transgenes expression. In da-Gal4/UAS-Topo
I#4 larvae, B52 distribution is extended towards the acidic part of
the gel reflecting a high level of phosphorylation (Figure 1B, panel
da-Gal4.UAS-Topo I#4). This effect is even more pronounced in
da-Gal4/UAS-Topo I#11 larvae, in which most of B52 is
dramatically shifted towards the acidic part of the gel (Figure 1B,
panel da-Gal4.UAS-Topo I#11). These results show that varying
the Topo I level modulates B52 phosphorylation status in vivo;
overexpression of Topo I increases B52 phosphorylation, whereas
the Topo I loss-of-function mutant displays a hypo-phosphoryla-
tion of B52. Thus, Drosophila Topo I has a conserved kinase activity
that modulates SR proteins phosphorylation in vivo.
To test if phosphorylation by Topo I regulated B52 activity, we
asked whether Topo I overexpression could modify the pheno-
types induced by B52 overexpression. We previously showed that
B52 overexpression during eye development induces strong
phenotypes in adult flies. Overexpression of B52 in the eye disc
before differentiation, under the control of the ey-Gal4 driver, gives
rise to flies harboring variable loss of ommatidia with about 2% of
flies totally lacking eyes [21]. Overexpression of B52 latter during
ommatidia differentiation of the eye using the GMR-Gal4 driver
gives rise to strongly reduced and disorganized eyes [22]. We
found that overexpression of Topo I significantly rescued the eye
phenotypes induced by B52 overexpression with the GMR-Gal4
driver (Figure 1D, panel GMR-Gal4+UAS-B52+UAS-Topo I#11)
and the ey-Gal4 driver (Figure 1E, Ey-Gal4+UAS-B52+UAS-Topo
I#11). These results suggest that B52 hyper-phosphorylation
mediated by Topo I represses its activity. Alternatively, given that
B52 overexpression can alter Topo I localization (see below), the
rescue can also be explained by a compensation of Topo I titration
by B52.
B52 and Topo I colocalize on polytene chromosomes
Previous studies have separately analyzed the distribution of
B52 and Topo I proteins on polytene chromosomes from salivary
glands of third instar larvae. These proteins were shown to
Author Summary
DNA Topoisomerase I (Topo I) is a very well known enzyme
capable of removing DNA topological constrains during
transcription. In mammals, Topo I also harbours an intrinsic
protein kinase activity required to achieve specific
phosphorylation of factors in charge of maturating the
transcript and exporting it from the transcription site in the
nucleus to the cytoplasm. In this report, we have used
Drosophila genetics to describe the surprising finding that
Topo I is not directly recruited to active transcription sites
by DNA but rather by an indirect interaction with its
protein target of phosphorylation which in turn is bound
to nascent transcripts at gene loci. Furthermore, we
demonstrate that the delivery of Topo I to an activated
heat shock gene is essential for efficient release of the
mRNA from its transcription site and functions to turn off
transcription of the gene. This study brings a new model
for the long unanswered question of how genes are
turned off and provides evidence that Topo I is at the heart
of the mechanism by which DNA and RNA processes are
coordinately regulated during development to avoid
genomic instability.
Role of Topo I and B52 in mRNA Release
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recruited to heat shock genes following their activation by heat
shock [23–25]. In order to map the relative localization of these
proteins to each other and to RNA Pol II, we raised a rat serum
against the last 16 amino acid residues of B52. We first compared
the distribution of B52 and Topo I on wild type polytene
chromosomes with the anti-B52 serum and anti-Topo I antibodies,
which were detected by appropriate secondary antibodies.
Remarkably, we observed an almost perfect overlap between
B52 and Topo I staining patterns on the chromosome arms where
most of the bands appeared as yellow signals reflecting colocaliza-
tion of B52 (red) and Topo I (green) (Figure 2A). To ensure that
there was no cross-hybridization with the secondary antibodies, we
repeated the same experiment by omitting one of the primary
antibodies, but keeping the two secondary antibodies. As expected,
only one signal is detected with each primary antibodies,
demonstrating absence of any cross detection (not shown).
To further address the colocalization of B52 and Topo I, we
took advantage of the Wee-P153 transgenic line that contains an
insertion of a GFP cassette in the first intron of the top1 gene [26].
This cassette is spliced into top1 transcripts and results in an in-
frame fusion of the GFP at the very N-terminus of Topo I,
allowing detection of Topo I through the GFP. Consistent with
colocalization of B52 and Topo I along chromosomes arms, a
perfect overlay was observed between B52 and GFP signals in the
Wee-P153 line (Figure 2B). This distribution was then compared to
that of RNA Pol II detected with the H14 monoclonal antibody,
which recognizes the RNA Pol II CTD phosphorylated on Ser5.
Consistent with previous reports, comparison of the RNA Pol II
staining pattern (green) with either B52 (red) or Topo I (grey)
staining revealed that not all chromosome sites have the same
degree of staining (Figure 2B). Some sites were intensively stained
with RNA Pol II, but only weakly with either B52 or Topo I
(Figure 2B and S1). Conversely, staining of some B52 and Topo I
sites did not always coincide with equivalent RNA Pol II staining
(Figure S1). The biochemical basis for the differential distributions
of Topo I/B52 proteins and RNA Pol II in some of chromosomal
loci is unknown; however, the possibility that this was due to the
nature of antibodies used can be ruled out, because similar results
were obtained using different sets of anti-RNA Pol II and anti-
Topo I antibodies [24,25, this study]. Therefore, the observed
variation in B52/Topo I versus RNA Pol II ratio probably reflects
differential requirements for Topo I and B52 activity between
transcribed loci.
B52 chromosomal distribution is not affected by Topo I
overexpression
Since Topo I overexpression can increase phosphorylation of
B52 in vivo, we decided to analyze whether overexpression of Topo
I in the salivary glands would perturb the localization of B52. To
perform targeted overexpression of Topo I in the salivary gland,
we drove expression of the UAS-Topo I#11 transgene with the
sgs3-Gal4 line [27] that expresses GAL4 exclusively in this tissue
from mid-third instar larval stage. Topo I overexpression in the
salivary glands (Figure 2C, panel Topo I and Figure 2D) induced a
shift of B52 mobility in western blots, reflecting hyper-phosphor-
ylation of B52 (Figure 2C, panel B52). In this context, B52 (red)
distribution was not significantly modified, as both proteins were
still colocalized along the chromosomes arms (Figure 2D, merge
Topo I and B52). Overexpression of Topo I enhances the banding
pattern detected with the Topo I antibody, as several faint bands
become very intense upon Topo I overexpression (Figure S2).
Remarkably, these bands coincide with stronger B52 signals
indicating that B52 recruitment to these sites is enhanced.
Nevertheless, while specific accumulation of Topo I could readily
be detected in the nucleolus, anti-B52 antibodies failed to stain this
organelle (Figure 2D, arrowhead), implying that B52 does not
accompany Topo I to the nucleolus.
B52 overexpression titrates Topo I in the nucleoplasm
Given that Topo I suppresses phenotypes induced by B52
overexpression (Figure 1D, E), it was important to determine the
consequences of B52 overexpression on Topo I localization. B52
overexpression in the salivary glands dramatically altered Topo I
distribution. Both B52 (red) and Topo I (green) accumulated
around the squashed chromosomes (Figure 3A). We confirmed this
observation in the WeeP-153 line: in B52-overexpressing nuclei,
GFP-Topo I accumulated around the squashed chromosomes as
did B52 (Figure S3). To ascertain that the relocalization of Topo I
seen on chromosomes spreads is not due to a technical artifact, we
analyzed the distribution of GFP-Topo I in intact salivary gland
nuclei, where GFP fluorescence is preserved compared to the
squashed preparation of chromosomes. In wild type nuclei, GFP-
Topo I is present on the chromosome arms, and in the nucleolus
(Figure 3B). Overexpression of B52 in the salivary glands of the
Wee-P153 line induces a massive relocalization of GFP-Topo I
from the chromosomes and the nucleolus, into the nucleoplasm
(Figure 3C). Interestingly, we observed that B52 overexpression in
the salivary gland nuclei led to an increase of the nuclear size
(Figure 3, compare B and C).
Whereas Topo I is redistributed in the nucleoplasm, RNA Pol II
distribution was not affected by B52 overexpression (Figure 3D,
panel Pol II in red) indicating that B52 does not displace
transcription factor complexes, but more specifically affects Topo I
recruitment on chromatin. In order to determine whether RNA
could participate in the accumulation of B52 and Topo I in the
nucleoplasm of B52-overexpressing nuclei, salivary glands were
incubated in the presence of RNase A prior to fixation and
squashed chromosomes were analyzed as before. RNase A
treatment abolished the nucleoplasmic signal seen in B52-
overexpressing nuclei (Figure 3E), indicating that nucleoplasmic
accumulation of B52 and Topo I is RNA-dependant.
B52 recruits Topo I to transcription sites
Physical interaction between Topo I and SR proteins has been
shown to modulate both DNA relaxation and SR protein
phosphorylating activities in mammals [28–31]. To determine
whether the Drosophila SR protein B52 can recruit Topo I by direct
Figure 1. Drosophila Topo I phosphorylates B52 in vitro and in vivo. (A) In vitro analysis of Topo I kinase activity with purified Topo I and B52 in
the presence of radioactive ATP. (B) Western blot analysis of B52 phosphorylation status after 2D electrophoresis, in wild type larvae (first panel),
mutant top1
77 larvae (second panel), or in larvae ubiquitously overexpressing Topo I weakly (third panel, genotype: UAS-Topo I#4/+, da-Gal4/+)o r
strongly (last panel, genotype: da-Gal4/UAS-Topo I#11). (C) Immuno-staining of wing imaginal discs with anti-Topo I antibody, in UAS-Topo I#4/+,en-
Gal4/+ (up) and en-Gal4/UAS-Topo I#11 larvae (bottom) showing that UAS-Topo I#11 is more efficiently activated by GAL4 than UAS-Topo I#4. (D, E)
Topo I rescues the phenotypes induced by B52 overexpression. Overexpression of B52 under the control of GMR-Gal4 (D) or ey-Gal4 (E) induces
phenotypes in adult flies that are partially rescued by concomitant expression of Topo I. Phenotypes obtained with the ey-Gal4 driver (E) are ranked
according to their severity: wild-type, slight disorganization of ommatidia, reduction of eye size and total loss of eye. 100 to 150 eyes were scored.
doi:10.1371/journal.pgen.1001124.g001
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expresses an inhibitory aptamer RNA (iaRNA) containing
stretches of high-affinity B52-Binding Sites (BBS) [32]. Expression
of this iaRNA under the control of a heat shock promoter was
previously shown to recruit B52 to the transgene transcription site
on polytene chromosomes after induction by heat shock [32]. In
our assay, targeted expression of UAS-BBS(5.12) in the salivary
gland under the control of the sgs3-Gal4 driver, led to a titration of
B52 at the transgene site (confirmed by immuno-FISH experi-
ments, data not shown) with a concomitant decrease of B52 signal
along the chromosomes (Figure 3F, panel B52 in red). In this
context of B52 titration with BBS, massive recruitment of Topo I
was similarly observed at the transgene insertion site (Figure 3F,
panel Topo I in green). The same result was observed with the
GFP-tagged Topo I when the UAS-BBS(5.12) transgene was
expressed in the Wee-P153 line: both B52 and GFP-Topo I are
strongly recruited to the transgene upon activation of its expression
by GAL4 (Figure S4). As a control, we analyzed the distribution of
the SR protein dASF in the same context as for B52. Unlike B52,
dASF was not recruited to the UAS-BBS(5.12) transcription site
(Figure 3G, panel dASF in green).
To further analyze the implication of B52 in the process of
Topo I recruitment to transcription sites, Topo I distribution was
tested in the context of B52 depletion. Since B52 loss-of-function
mutants are lethal at the second instar larval stage, we attempted
to deplete B52 by RNAi to obtain third instar larvae from which
polytene chromosomes preparation is more convenient. To this
end, we used a UAS-IR-B52 transgene which carries an inverted
repeat hairpin targeting B52 under the control of UAS sequences.
Expression of the UAS-IR-B52 transgene under the control of the
ubiquitous da-Gal4 driver (thereafter called B52
da-RNAi) induced
lethality at 25uC, mainly during the pupal stage, with only rare
adults recovered. Notably, B52
da-RNAi third instar larvae displayed
smaller salivary glands and western blot analysis showed that B52
was significantly depleted and hypo-phosphorylated in B52
da-RNAi
salivary glands (Figure 4B, panel B52). Immunostaining of these
salivary glands revealed that B52 depletion is not always efficient
in all cells, and that B52-depleted cells are smaller than B52-
positive cells (Figure 4A, panel B52 in red). This peculiar property
offers the opportunity to compare B52-depleted cells to control
cells in the same salivary gland. We observed that Topo I
distribution was dramatically different between wild type and B52-
depleted nuclei; whereas Topo I is mainly present on the
chromosome arms in wild type cells (Figure 4C), most Topo I
staining was detected in the nucleolus of B52 depleted nuclei
(Figure 4D). The accumulation of Topo I in the nucleolus was
confirmed by co-staining with anti-fibrillarin antibodies (Figure
S5). This effect was strongly evident on squashed preparations of
polytene chromosomes. To allow a robust comparison of immuno-
stainings, wild type and B52
da-RNAi salivary glands were mixed on
the same slide and treated as unique sample. Chromosomes from
B52
da-RNAi larvae, which are clearly identified by the absence of
B52 signal, displayed a faint Topo I signal on the chromosome
arms, with fewer bands compared to wild type (Figure 4E and F
compare panels Topo I in green). Topo I signal was, however,
mainly detected in enlarged nucleoli (Figure 4F). These results
indicate that B52 depletion impairs localization of Topo I on
polytene chromosomes, allowing its accumulation in the nucleolus.
Depletion of B52 impairs hsp70 shutdown and hsp70
mRNA release
Both B52 and Topo I were previously shown to be strongly
recruited to heat shock (HS) genes after their induction by heat shock
[23–25]. As most HS genes lack introns, this observation suggests a
splicing-independent role of B52 at these sites. Based on above
observations, B52 could also participate to Topo I recruitment on
HS genes. Therefore, we analyzed Topo I and RNA Pol II
recruitment on HS loci after induction by heat shock in B52-
depleted polytene chromosomes, compared to the wild type. We
used the endogenous GFP-tagged Topo I for convenience. As
expected, both GFP-Topo I (grey) and B52 (red) are recruited to
HS genes after heat shock induction (Figure 5A). However, GFP-
Topo I recruitment on HS loci is dramatically reduced in B52-
depleted chromosomes (Figure 5B), whereas RNA Pol II (green) is
still detected after heat shock (compare Figure 5A and B). It should
be noted that B52 depletion by RNAi is not complete. Low levels
of B52, which is barely detectable on chromosomes in the absence
of heat shock (Figure 4F), become concentrated on HS loci after
activation. This residual B52 could be the cause of moderate
detection of Topo I at HS loci. Altogether, these data show that
B52 plays a major role in Topo I recruitment to HS transcription
sites.
To determine the functional consequences of the B52-mediated
recruitment of Topo I to HS genes transcription, we focused our
study on the intron-less hsp70 gene which enabled us to analyze
B52 function independently of its role in RNA splicing. We first
performed a kinetic analysis of hsp70 mRNA expression by
northern blot in wild type, B52 mutants and Topo I mutant larvae
(Figure 6A). In the wild type situation, hsp70 mRNA was strongly
detected immediately after 40 min heat shock (Figure 6A, Control,
lane 0), and disappeared almost completely 2 hours after heat
shock (see lanes 2 and 4 hours after HS), due to short mRNA half-
life and to hsp70 transcription shut down [33]. To analyze hsp70
expression in B52 and Topo I mutant backgrounds, we used both
the available mutants or RNAi-mediated depletions. Since the
original B52 mutant, B52
28, contains a deletion that disrupts both
B52 and the neighboring gene Hrb87F, we used this mutant in
combination with the B52
s2249 allele which contains an insertion of
a transposable element in the 59UTR of the B52 gene. This
mutant dies at the second and third instar larval stages. As in the
wild type, hsp70 mRNA was strongly induced after heat shock in
B52
28/B52
s2249 heterozygote as well as in B52
s2249 homozygote
larvae (Figure 6A). This result is consistent with previous data
showing that induction of hsp70 is not impaired in the B52
28
mutant [34]. However, in this genetic background hsp70 mRNA is
still detected 4 hours after the end of the heat shock. The same
result was obtained in B52
da-RNAi larvae that express an RNAi
against B52 (Figure 6B). This observation may reflect changes in
hsp70 mRNA decay or a prolonged expression of the gene after the
end of the heat shock. Strikingly, the same results were obtained in
the top1
77 mutant (Figure 6A) as well as in larvae expressing an
RNAi against Topo I (top1
da-RNAi) (Figure 6B). While hsp70
the Wee-P153 line (expressing an endogenous GFP-Topo I fusion) stained with anti-B52, anti-GFP and anti-RNA Pol II Ser5P antibodies. The pattern of
B52 and GFP staining is almost identical, as observed with B52 and Topo I antibodies. B52/Topo I distribution overlaps with RNA Pol II signal,
nevertheless the intensities of the labeled bands do not always correlate. (C) Western blot analysis of control (genotype: sgs3-Gal4/+) or Topo I-
overexpressing (Topo I OE, genotype: sgs3-Gal4/UAS-Topo I#11) salivary glands extracts. (D) Immunodetection of B52 and Topo I on polytene
chromosome from salivary glands overexpressing Topo I (sgs3-Gal4/UAS-Topo I#11 larvae). Note that B52 is not detected in the nucleolus
(arrowhead) unlike Topo I.
doi:10.1371/journal.pgen.1001124.g002
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detected 4 to 6 hours after the end of the heat shock.
These results are reminiscent of the defects observed in
Drosophila mutants for the P68 RNA helicase. In p68 mutants,
hsp70 mRNA gene deactivation is delayed, and this correlates with
impaired release of hsp70 mRNA from its transcription sites [35].
Therefore, we asked whether B52 depletion could also impair
hsp70 mRNA release. We analyzed hsp70 mRNA distribution in
salivary glands from B52
da-RNAi larvae by in situ hybridization
(Figure 5C). After 20 min heat shock, hsp70 mRNA (red) strongly
accumulates at its transcription sites in B52-depleted cells, but
never in B52-positive cells (Figure 5C). Despite its accumulation at
transcription sites, hsp70 mRNA is clearly detected in the
nucleoplasm of B52-depleted nuclei, indicating that hsp70 mRNA
export is not completely blocked. Consistently, immunoblot
analyses showed that HSP70 protein is expressed after heat shock
in B52- and Topo I-depleted larvae (Figure 6B), indicating that
hsp70 mRNA is properly processed, exported and translated in
these mutants. Remarkably, HSP70 protein level continues to
increase 4 to 6 hours after the end of the HS in B52- and Topo I-
depleted larvae compared to wild type. This is consistent with the
prolonged expression of the hsp70 mRNA detected by northern
blot. Taken together, our results show that B52 depletion impairs
hsp70 mRNA release from its transcription sites and causes an
extended expression of hsp70 after HS, suggesting a defect in
transcription deactivation.
To directly address this hypothesis, we analyzed the distribution
of RNA Pol II on the hsp70 gene by chromatin immunoprecip-
itation after cross-link (X-ChIP) with anti-RNA Pol II antibodies,
followed by quantitative PCR (q-PCR). We reasoned that if
transcription shutdown is impaired by B52 depletion, we should
be able to detect RNA Pol II on the hsp70 genes several hours
after HS. We analyzed four regions covering the hsp70 gene and a
negative control, in wild type and B52-depleted larvae, at 3 time
points: before HS, just after HS and 3 h after the end of the HS
(Figure 6C). As expected, we observe that RNA Pol II is strongly
recruited on hsp70 after HS, both in WT and B52-depleted
contexts. Remarkably, 3 h after the end of the HS, we detect
more RNA Pol II on hsp70 in the B52-depleted context (roughly 2
fold) than in the wild type. This result provides a direct evidence
that hsp70 transcription is maintained at a higher level in B52-
depleted larvae than in wild type. Altogether our results show that
B52 is required for efficient hsp70 mRNA release from its site of
transcription and shutdown of hsp70 transcription after heat
shock.
Discussion
SR protein splicing factors can interact with mammalian Topo I
as a recombinant protein in vitro and they coimmunoprecipitate
from nuclear extract [29–31]. This interaction between Topo I
and SR proteins allows Topo I to achieve specific phosphorylation
of SR proteins [29,30,36]. Thus, depletion of Topo I from
mammalian cells results in the hypo-phosphorylation of SR
proteins, impaired SR protein-dependent splicing and increased
genomic instability due to R-loop formation [18,19]. The present
study provides compelling in vivo evidence that the targeting of
Topo I to active transcription sites is part of the mechanism by
which the SR protein B52 functions in Drosophila. B52 was only
previously known to be important for regulating alternative
splicing [34,37,38]. However, this mechanism cannot explain the
recruitment of B52 to intron-less genes like heat shock (HS) genes
[23,24]. The delivery of Topo I by B52 may represent a novel
mechanism involved in the control of gene expression. In
Drosophila salivary glands both B52 and Topo I are strongly
recruited to HS genes after heat shock ([23,24] and here Figure 5)
but depletion of neither protein affected hsp70 gene induction
([34,37] and Figure 6A,B). B52-mediated recruitment of Topo I to
the activated hsp70 loci appears to be essential for efficient release
of hsp70 mRNA from its transcription sites and to turn off
transcription. In B52- or Topo I-depleted cells, expression of hsp70
is abnormally maintained several hours after the end of induction
(Figure 6). Also, hsp70 mRNA is strongly retained at its
transcription sites when B52 is depleted (Figure 5C). These
findings support the notion that efficient release of mRNPs and
transcription shutdown are coupled processes requiring targeted
recruitment of Topo I to active chromatin by B52.
Because of its ability to dissolve both positive and negative
supercoils from constrained DNA, it has been proposed that Topo
I provides swivels for removing torsional constraint that accom-
panies DNA-associated processes [14]. However, there is no
evidence that Topo I alone directly drives the elongation of
transcription through its relaxing activity. In fact, the DNA
relaxation activity has been shown to be dispensable for both
repression and activation of transcription in reconstituted
transcription reactions [12,13]. Studies with yeast DNA topoisom-
erase mutants further support the idea that Topo I is not essential
for transcription by RNA Pol II [7,11,39]. However, plasmids
carrying transcriptionally active genes are found to be extremely
negatively supercoiled when isolated from mutants lacking Topo I
[39], implying that a major function of Topo I is to remove
negative supercoils after transcription elongation. Moreover, Topo
I mutants including strains with null mutations are viable and
exhibit no obvious growth defects, demonstrating that Topo I is
not essential for viability in yeast [7,11,39]. Rather, yeast Topo I
seems to be required for gene repression during a critical period
when cells approach and enter the stationary phase [40]. In
contrast, depletion of zygotic and maternal Topo I in Drosophila
leads to an early embryonic lethal phenotype [41]. The data
presented here indicate that Topo I is involved in programmed
gene shut-off at hsp70 locus, which likely plays a complementary
and essential role to gene activation during Drosophila develop-
ment. The mechanisms that are responsible for transcription
attenuation during the recovery phase after heat shock are not
precisely known. Studies in many eukaryotes have established that
heat shock genes repression requires the heat shock protein
themselves, which participate in a negative autoregulation loop.
In mammals for example, HSP70 protein associates with HSF1
Figure 3. B52 influences Topo I localization. (A–E) B52 overexpression induces nucleoplasmic accumulation of B52 and Topo I in an RNA-dependant
manner. (A) Squashed polytene chromosomes from B52-overexpressing (B52 OE) salivary glands, stained with anti-B52 and anti-Topo I antibodies.
(B-C) Visualization of GFP-Topo I fluorescence in intact nuclei from Wee-P153 line salivary glands in a wild-type (B) or in a B52-overexpressing context
(C). (D–E) Immuno-staining of squashed polytenes chromosomes from the Wee-P153 line over-expressing B52 in the salivary glands. In this context,
GFP-Topo I accumulates in the nucleoplasm, whereas RNA Pol II is not affected. (E) RNase A treatment of the nuclei prior to fixation removes the
nucleoplasmic staining of B52 and Topo I. (F-G) Immuno-staining of squashed polytenes chromosomes expressing the UAS-BBS(5.12) transgene, with
anti-B52 and anti-Topo I antibodies (F) or with anti-B52 and anti-dASF antibodies (G). The position of the transgene, which titrates B52, is indicated by
an arrow. Topo I is strongly recruited to this site compared to the SR protein dASF. Genotypes: (A) w/Y; sgs3-Gal4/UAS-B52. (B) y,w,Wee-P153/Y; sgs3-
Gal4/+. (C-E) y,w,Wee-P153/Y; sgs3-Gal4/UAS-B52. (F,G) sgs3-Gal4/UAS-BBS(5.12).
doi:10.1371/journal.pgen.1001124.g003
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shock genes transcription [37,42]. Moreover, it was shown in
Drosophila that a certain level of HSP70 protein produced is
necessary to trigger repression of HS genes transcription [33,37].
In our experiments, we observed that HSP70 protein is expressed
but continues to accumulate several hours after HS in the B52-
depleted context, compared to the wild type. Therefore the
amount of HSP70 protein is certainly not limiting for the
autoregulation to take place. Our results more likely suggest that
B52 and Topo I participate to hsp70 transcription shutdown by
promoting hsp70 mRNA clearance from its transcription sites, as it
has been shown for the RNA helicase P68 [35,37]. Gene
activation involves both changes in chromatin structure and
assembly of maturing transcripts with complexes involved in their
Figure 4. B52 depletion induces accumulation of Topo I in the nucleolus. (A) Immunostaining of salivary gland from larvae expressing
inverted repeats against B52 (B52
da-RNAi, genotype: da-Gal4/UAS-IR-B52). Several nuclei escape the RNAi effect and show B52 labeling and diffuse
Topo I localization, whereas B52-depleted cells, which are smaller, display a bright spot of Topo I staining in the center of the nuclei. (B) Immunoblot
on salivary gland extracts from control (da-Gal4/+) or B52-depleted (da-Gal4/UAS-IR-B52) larvae. (C,D) Optical section through the middle of salivary
glands nuclei from control (C) and B52
da-RNAi (D) third instar larvae, stained with anti-Topo I antibody. (E,F) Immuno-staining of squashed polytenes
chromosomes from control (da-Gal4/+) and B52
da-RNAi (F) third instar larvae salivary glands.
doi:10.1371/journal.pgen.1001124.g004
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such intimate coupling, many RNA-binding proteins are found in
close contact with template DNA, which is detectable by
chromatin immunoprecipitation (ChIP) in all eukaryotic cells
[43,44]. Among these factors are members of the SR protein
family. Thus, to coordinate mRNP release and transcription
shutdown Topo I has acquired novel properties. Among these, are
the abilities of Topo I to phosphorylate SR proteins [4,20] and to
interact with RNA-binding proteins involved in pre-mRNA
splicing like SF2/ASF, hnRNP A/B, PSF and p54
nrb [17,29–31].
Recently, a proteomic analysis of Topo I-purified complexes
identified 36 Topo I partners, 24 of which are involved in RNA
metabolism [45]. These include nucleolin, a nucleolar phospho-
protein, which is implicated in the synthesis and maturation of
ribosomes [46]. Consistent with the requirement for Topo I during
ribosomal RNA synthesis, Topo I interacts also with RNA
polymerase I [11,39,47]. Furthermore, the most prominent
phenotype associated with top1 mutants in yeast is an altered
chromatin structure at the rDNA locus [11,39,47,48], suggesting
that the enzyme might be involved in chromatin remodeling at this
locus. Given that B52 depletion in Drosophila leads to nucleolar
accumulation of Topo I (Figure 4F), it is possible that proteins with
RRM domain, like nucleolin, are involved in the localization of
Topo I in the nucleolus. SR proteins could compete with nucleolar
protein(s) for the distribution of Topo I between the nucleolus and
nucleoplasm (Figures 3 and 4). These data invoke a striking
parallel between coordination of transcription and processing
events for RNA Pol II and RNA Pol I by SR proteins and
nucleolin respectively. Similar to SR proteins function at RNA Pol
II loci, the interaction of nucleolin with nascent pre-rRNA has
been shown to help the co-transcriptional assembly on pre-rRNA
of factors necessary for the subsequent maturation of the pre-
ribosomal particle [46]. Thus, the involvement of nucleolin at
multiple steps of ribosomal RNA biogenesis pathway suggests that
it could play a key role in this highly integrated process including
the release of rRNP particles. It is not known whether the kinase
activity of Topo I is also required in the nucleolus. Interestingly,
the interaction between the RNA-binding domains of the SR
protein SF2/ASF and Topo I inhibits its DNA relaxation activity
without affecting its kinase activity [29] therefore it is tempting to
speculate that the RNA-binding domain of nucleolin and/or other
nucleolar RNA-binding proteins could similarly inhibit the
relaxing activity of Topo I and/or act as a mediator of Topo I
localization.
Figure 5. B52 depletion impairs Topo I recruitment at the HS gene transcription sites and hsp70 mRNA release. (A-B) Immuno-staining
of squashed polytenes chromosomes from control (da-Gal4/+) and B52
da-RNAi larvae after heat shock, with anti-RNA Pol II ser5P, anti-B52 and anti-
Topo I. The positions of the hsp70 loci are indicated by arrows. (C) Analysis of hsp70 RNA localization by in situ hybridization in B52-depleted (da-Gal4/
UAS-IR-B52) salivary glands, after 20 min heat shock, combined with immuno-detection of B52 protein. hsp70 transcription sites are indicated by
arrows. In this experiment, one cell escapes the RNAi effect and still expresses B52. In this cell hsp70 RNA does not accumulate at its transcription site.
doi:10.1371/journal.pgen.1001124.g005
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to formation of RNA/DNA hybrids known as R-loops that trigger
genomic instability [2,19,49–51]. Loss of mammalian SF2/ASF
has been shown to lead to extensive pairing between the nascent
transcripts and template DNA, allowing R-loop formation and
consequently genomic instability [52] and Topo I is the major
activity that suppresses the deleterious effect of R-loop formation
in E. coli [50] and in mammals [19]. In E. coli, transcribed RNA is
translated directly, whereas in mammals primary transcripts are
processed and associated with export factors in the nucleus before
being translated in the cytoplasm. So translation and processing
have evolved to protect against R-loops in bacteria and
eukaryotes, respectively. R-loop formation is more extensive on
hypernegatively supercoiled templates that are generated following
Topo I depletion in different organisms [2,19,50]. Since
transcription-induced R-loop formation is a problem in all
organisms [52], B52-mediated loading of Topo I on RNPs may
have evolved to avoid R-loop formation in Drosophila. One
function of B52 is to help to restore unconstrained DNA
conformation by bringing Topo I to sites of active transcription
(see model Figure 7). On the other hand, B52 facilitates the release
of mRNAs and their export to keep transcripts away from actively
transcribed DNA and thereby prevent its re-hybridization with
DNA from which it originates.
Works in a variety of organisms suggest that newly assembled
mRNPs are tethered to chromatin to ensure that only properly
processed RNAs are released for export [2]. Depletion of factors,
including B52, that are involved in RNP processing and export
leads to mRNP accumulation at the site of transcription
(Figure 5C). In mammals SR proteins have been shown to
interact with the export factors TAP(NXF1)/p15 and facilitate
export [53]. Studies of RNA export in Drosophila suggest that the
pathway has been highly conserved [54]. Interaction between B52
and Drosophila NXF1/P15 may allow nascent transcripts to leave
their sites of synthesis and undergo transport to nuclear pores.
Since this interaction is dependent on the phosphorylation status
of SR proteins in mammals [53], it can be assumed that Topo I-
mediated phosphorylation could similarly have an impact on
mRNP release and export (see model presented Figure 7).
Recently, we have shown that mammalian Topo I deficient
cells, unlike yeast top1D mutants, display an increased rate of fork
stalling during DNA replication due to R-loop formation [19].
Absence of a kinase activity associated with yeast Topo I could
explain the difference in the phenotype between mammalian and
yeast Topo I-deficient cells [19]. Consistent with our model that
Topo I/kinase as well as SR proteins interfere with R-loop
formation, is the observation that inhibition of this activity with
Diospyrin [55] or depletion of ASF/SF2 in cells expressing Topo I
[19] reproduces the replication defects and genomic instability of
Topo I-deficient cells. These defects are, however, fully suppressed
by inhibiting transcription or by degrading DNA-RNA hybrids
with RNase H [19]. Thus, SR protein-mediated Topo I
recruitment to active transcription sites and subsequent transcrip-
tion shutdown is likely to be a key mechanism for preventing
genomic instability during DNA replication. Consistent with this
prediction is the finding that chromosome breaks preferentially
occur at gene-rich regions in the absence of Topo I and their
accumulation was directly proportional to the level of gene
expression [19]. Interestingly, chromosomal breaks in Topo I-
deficient cells accumulate at replication-dependent histone genes
which are highly expressed in S-phase and are rapidly downreg-
ulated when DNA replication is repressed [56,57]. Failure to
shutdown histone genes expression could be a major source of
interference between replication and transcription and could
explain differences in the sensitivity of various cell types to specific
inhibitors of Topo I, like CPT and its derivatives [5,58].
Materials and Methods
Fly strains, transgenic lines and Drosophila genetics
The B52 mutant B52
28, as well as UAS-B52 and UAS-BBS(5.12)
transgenic lines were kindly provided by John Lis. The mutants
B52
s2249 and top1
77 were obtained from Bloomington Drosophila
stock center. B52
28 contains a deletion that disrupts both B52 and
the neighboring gene Hrb87F [37]. B52
s2249 corresponds to an
insertion of a transposable element in the 59UTR of the B52 gene
(Flybase). top1
77 contains a rearrangement in the 39 region of the
top1 gene [8]. These mutants die at the second instar larval stage.
The Wee-P153 line [26] was kindly provided by Graeme Davis.
The UAS-IR-B52 and UAS-IR-top1 transgenic lines were obtained
from the Vienna Drosophila RNAi Center. UAS-Topo I transgenic
flies were generated as follows. The Drosophila Topo I open reading
frame (ORF) was PCR-amplified from a clone containing a top1
cDNA (pcTop1-2 clone, kindly provided by Tao Hsieh) and
cloned in the BglII and XbaI sites of pUAST. This construct was
injected into w
1118 embryos together with a source of P transposase
using conventional methods.
Kinase assays and 2D gels
A BglII-XbaI PCR fragment corresponding to the Drosophila
Topo I coding sequence was cloned in the BamHI and XbaI sites of
pFastBac1 expression vector (Invitrogen). Topo I protein was
expressed in SF9 cells and purified on nickel columns via an
endogenous stretch of 7 histidines present at the very N-terminus
of the protein. B52 was expressed in bacteria as a His-tagged
protein and purified on NiNTA agarose beads (Qiagen). Kinase
assays were performed as described in [30]. 2D gels were
performed as described in [17]. B52 was detected by the
mAb104 antibody followed by ECL staining.
Immuno-stainings
Immuno-staining of polytene chromosomes was performed as
described in [59]. Larvae were raised at 25uC instead of 18uCt o
allow efficient activity of the Gal4 drivers, except for the
chromosome in Figure 3A, which was obtained at 18uC in order
to improve cytology of the chromosomes. RNase A treatment of
polytene chromosomes squashes was performed as described in
[60]. Rabbit anti-Topo I (1/400) antibodies were kindly provided
by Tao Hsieh. Anti-Pol II mAb H14 was purchased (Covance). To
detect GFP-Topo I on squashed polytene preparations, we used a
Figure 6. B52 and Topo I are required for hsp70 transcription shutdown. (A) Kinetic analysis of hsp70 mRNA expression by northern blot
before (No HS) and after 40 min heat induction in control (w
1118), B52 mutants (B52
s2249 homozygotes and B52
28/B52
s2249 heterozygotes), and Top1
mutant (top1
77) larvae. 28S rRNA serves as a loading control. (B) Kinetic analysis of hsp70 expression before (No HS) and after 40 min heat induction in
control by northern blot and western blot on control (da-Gal4/+), B52-depleted (da-Gal4/UAS-IR-B52) and Topo I-depleted (da-Gal4/UAS-IR-Top1) third
instar larvae. (C) Distribution of RNA Pol II on hsp70 gene determined by Chromatin-ImmunoPrecipitation and quantitative PCR. The primer pairs are
indicated below the hsp70 gene model. The histogram represents the percentage of chromatin immunoprecipitated by anti-RNA Pol II antibody (Top
panel) or no antibody (Mock, bottom panel), before heat shock (no HS), just after 40 min heat activation (HS+0) or after 3 h of recovery following HS
(HS+3 h).
doi:10.1371/journal.pgen.1001124.g006
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GFP fluorescence is destroyed by the fixation method employed.
The anti-B52 serum was raised in rats by Eurogentec against the
sequence KNGNASPDRNNESMDD, which corresponds to the
last 16 amino acids of B52. This serum was purified with the
Melon Gel IgG Purification Kit (Pierce). This serum recognizes a
single polypeptide of 52 kDa in western blots, corresponding to
B52 (Figure 2C and 4B, panel B52), moreover no signal is detected
with this serum on B52 mutant chromosomes (not shown) or on
chromosomes from B52-depleted larvae (Figure 4F), indicating
that the staining is specific for B52. It recognizes the same band on
western and on polytene chromosomes as a rabbit serum raised
against the same peptide [21]. The purified rat anti-B52 antibody
was used at 1/50 dilution on squashed polytene chromosomes.
Secondary antibodies from Molecular Probes were used at a
dilution of 1/400 (anti-rat-Alexa546, anti-rabbit-Alexa488, anti-
mouse IgM-Alexa488, anti-rabbit-Cy5). For staining of larval
imaginal discs, anti-Topo I antibody was used at 1/2000. For
staining of intact salivary glands, anti-B52 was used at 1/500, anti-
Fibrillarin monoclonal antibody 72B9 was used at 1/100, and
Figure 7. Proposed model of the coordination between nascent mRNP release and DNA supercoiling mediated by SR protein B52
and Topo I. (A) In wild type nuclei, B52 (purple) and other RNA binding proteins (green, yellow and red) travel with transcribing polymerase to scan
emerging transcript for cis acting sequences and help release of RNA from the DNA template. B52 recruits Topo I both to remove negative supercoils
generated behind the polymerase, preventing formation of large extended single stranded DNA and to mediate its phosphorylation, thereby
changing its interaction properties with other partners of the export machinery. (B) In the absence of B52, recruitment of Topo I is impaired leading to
R-loop formation between nascent transcript and negatively supercoiled DNA template thereby retarding elongation of RNA Pol II complex and
release of export-competent mRNP necessary for transcription shutdown.
doi:10.1371/journal.pgen.1001124.g007
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or polytene chromosomes were all stained with Hoechst and
mounted in Prolong Gold Antifade (Molecular Probes). Images
were acquired on a Zeiss AxioimagerZ1 drived by Metamorph for
conventional fluorescence, or by Axiovision for acquisition with
Apotome. Overlay images were reconstituted in Adobe Photoshop
software.
hsp70 expression analysis
For RNA-FISH analysis, third instar larvae were heat shocked
during 20 min at 37uC in a water bath. To prepare the RNA
probes, a 1.1 kb PCR fragment corresponding to the 59 half of
hsp70 gene was cloned in pCR II vector (Invitrogen). This plasmid
was linearized by restriction enzyme digestion and in vitro
transcribed with SP6 or T7 RNA polymerase (Biolabs) in the
presence of digoxigenin-labeled UTP (Roche Diagnostics) to
produce antisense or sense probe respectively. The probes were
purified with RNeasy kit (Qiagen). In situ hybridization was
performed as described in [61] with 50 ng of RNA probe.
Following hybridization, RNA probes were detected with mouse
anti-DIG antibodies (1/500, Roche Diagnostics). B52 and Topo I
proteins were detected with purified rabbit anti-B52 (1/500) and
rabbit anti-Topo I (1/2000) antibodies respectively. Secondary
antibodies (anti-mouse-Alexa555 and anti-rabbit-Alexa488 from
Molecular Probes) were used at 1/4000. Hybridization with the
sense probe gave no signal, as expected (not shown).
To prepare Northern blots, total RNA was extracted from wild
type or mutant larvae with tri-reagent (Sigma), and quantified with
Nanodrop. Mutant larvae (B52
S2249, B52
S2249/B52
28, and top1
77
were heat shocked at the second instar, whereas we used third
instar larvae for RNAi mediated depletion. The larvae were heat
shocked during 40 min at 37u and allowed to recover between 0 to
6 h at 25uC. 5 mg of total RNA was loaded on a 1.3% agarose gel
containing 6% formaldehyde. RNAs were transferred to nitrocel-
lulose membrane in 10X SSC and then cross-linked by baking the
membrane 3 h at 80uC. The plasmid containing the 1.1 kb PCR
fragment corresponding to the 59 half of hsp70 gene was used to
prepare the hsp70 probe. The probes were prepared by random
priming in the presence of
33P-dCTP and purified with
NucleoSpin Extract II kit (Macherey-Nagel). Hybridization was
performed overnight at 42uC. Radiactive signals were detected by
phosphor-imager.
For western blots, HSP70 protein was detected with a
monoclonal anti-HSP70 (5A5, Thermo Scientific) and ECL
detection (Pierce).
Chromatin immunoprecipitation
Wild type and B52 RNAi third instar larvae were homogenized
with dounce in fixation solution buffer A (50 mM Hepes, 1 mM
EDTA, 0.5 mM EGTA, 15 mM NaCl, 60 mM KCl, 0.1%
tritonX-100 and Protease inhibitor cocktail SetI (Calbiochem))
containing 1.8% formaldehyde. Homogenates were filtered
through 100 mm filters. After 12 min fixation, glycine was added
to 0.225 M. Nuclei were pelleted by centrifugation, washed twice
in buffer A, and finally resuspended in buffer B (50 mM Hepes,
1 mM EDTA, 1% NP40, 0.1% SDS, 0.1% NaDeoxycholate and
Protease inhibitor cocktail SetI (Calbiochem)) containing 140 mM
NaCl. Nuclei were sonicated 10 times 30 sec on ice with a Vibra-
Cell ultrasonic processor, at amplitude 50. Debris were pelleted by
centrifugation 5 min at 16000 g. Soluble chromatin was pre-
cleared 1 h with magnetic protein-G Dynabeads (Invitrogen) at
4uC. For immunoprecipitation, chromatin corresponding to
approximately 10 larvae was incubated overnight at 4uC with
anti-RNA Pol II antibody (8WG16, 4 ml) or no antibody (Mock) in
the presence of 30 ml protein-G Dynabeads. Beads were washed at
room temperature in buffer B containing 140 mM NaCl
(365 min), then 300 mM NaCl (365 min), then 250 mM LiCl
(265 min), and finally in TE (265 min). Elution from the beads
was performed at 65uC with 300 ml elution buffer (100 mM
NaHCO3, 1% SDS) and shacking. To reverse the crosslinks, NaCl
was added to 300 mM and the tubes were incubated 7 h at 65uC.
After RNase A and proteinase K treatments, DNA was purified by
phenol-chloroform extraction and ethanol precipitation, and
finally dissolved in 60 mlH 2O.
Quantitative PCR analysis
Real-time PCR was performed using SYBR Green and the
LightCycler 480 real-time PCR system (ROCHE), in 10 ml with
2.5 ml purified DNA per reactions. PCR settings: 2 min 95uC; 45
cycles: 10 s 95uC, 15 s 68uC, 25 s 72uC. Data were collected at
72uC. PCR were performed in triplicates on two independent
immunoprecipitations. For each PCR and each chromatin
preparation, a standard curve is made on purified input DNA
(purified from aliquots of chromatin taken before immunoprecip-
itation). The amount of target sequence in immunoprecipitated
DNA samples was expressed as a percentage of DNA present in
the input material. We used primers for hsp70 sequences centered
at 2154 (from 2200 to 2108), +378 (from 334 to 423), +1426
(from 1363 to 1490) and +1951 (from 1925 to 1978), as described
by Boehm et al. [37,62]. Primers located downstream from the
hsp70 gene in the Octb3R gene [37,63] are used as a negative
control.
Supporting Information
Figure S1 Polytene chromosomes from Wee-P153 larvae, triple
stained with anti-B52, anti-GFP (revealing GFP-Topo I) and anti-
Pol II antibodies. The right panel shows composite images of B52
and Topo I staining or B52 and Pol II staining, presented as
overlay or split along half of each chromosome.
Found at: doi:10.1371/journal.pgen.1001124.s001 (1.59 MB TIF)
Figure S2 Immunodetection of B52 and Topo I on polytene
chromosomes from control (sgs3-gal4/+) or Topo I-overexpressing
(sgs3-gal4/UAS-Topo I#11) salivary glands. Overexpression of
Topo I enhances the banding pattern detected with the Topo I
antibody, as faint bands become strongly visible upon Topo I
overexpression. Note, Topo I staining coincides with stronger B52
signal.
Found at: doi:10.1371/journal.pgen.1001124.s002 (0.94 MB TIF)
Figure S3 (A) Immunodetection of B52 and GFP-Topo I on
polytene chromosome from salivary glands of the WeeP-153 line,
overexpressing B52 (genotype: y,w,WeeP-153/Y; sgs3-gal4/+; UAS-
B52/+). (B) Western blot analysis of control (genotype: sgs3-gal4/+)
or B52-overexpressing (B52 OE, genotype: sgs3-gal4/+; UAS-B52/
+) salivary gland extracts.
Found at: doi:10.1371/journal.pgen.1001124.s003 (0.74 MB TIF)
Figure S4 Fragments of polytene chromosomes surrounding the
insertion point of the UAS-BBS(5.12) transgene (arrowhead), in the
absence (A) or presence (B) of the driver sgs3-gal4. Chromosomes
are shown stained with anti-B52 and anti-GFP antibodies (the
latter detects GFP-TopoI). In the presence of GAL4, expression of
UAS-BBS(5.12) is strongly activated, creating a puff at the
transgene insertion site (B). Both B52 and TopoI are strongly
recruited to this site. Genotypes: (A) y,w,WeeP-153/Y; UAS-
BBS(5.12)/+ and (B) y,w,WeeP-153/Y; UAS-BBS(5.12)/sgs3-gal4.
Found at: doi:10.1371/journal.pgen.1001124.s004 (1.14 MB TIF)
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(y,w,WeeP-153/Y; da-gal4/+) or B52-depleted larvae (y,w,WeeP-
153/Y; da-gal4/UAS-IR-B52), with anti-B52 and anti-fibrillarin
antibodies. GFP-Topo I is detected by the intrinsic fluorescence of
GFP.
Found at: doi:10.1371/journal.pgen.1001124.s005 (2.55 MB TIF)
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